A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT07260877

Public ClinicalTrials.gov record NCT07260877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT07260877
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Ventus Therapeutics U.S., Inc.; Industry
Enrollment: 24 participants

Conditions and interventions

Conditions

Interventions

VENT-03 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2, 2025
Primary completion: Jun 30, 2026
Completion: Aug 31, 2026
Last update posted: Apr 5, 2026

2025 – 2026

United States locations

U.S. sites: 10
U.S. states: 6
U.S. cities: 10

Facility	City	State	ZIP	Site status
Investigative Site	Beverly Hills	California	90211	Recruiting
Investigative Site	Clearwater	Florida	33765	Recruiting
Investigative Site	DeBary	Florida	32713	Recruiting
Investigative Site	Tampa	Florida	33606	Recruiting
Investigative Site	Saint Joseph	Missouri	64506	Recruiting
Investigative Site	Fairport	New York	14450	Recruiting
Investigative Site	Memphis	Tennessee	38119	Recruiting
Investigative Site	Allen	Texas	75013	Recruiting
Investigative Site	Arlington	Texas	76012	Recruiting
Investigative Site	Colleyville	Texas	76034	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07260877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 5, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07260877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →